Tag
Norris Medicines Limited
2 articles
Norris Medicines 35th Annual Report FY26 Submission
Norris Medicines submitted its 35th Annual Report for FY 2025-26 to BSE, reporting a reduced net loss of ₹28.06 lakhs on revenue of ₹813.20 lakhs.
The AGM notice includes special resolutions to appoin
Norris Medicines 35th AGM Notice FY2025-26
Norris Medicines schedules its 35th AGM for 29th September 2026 via VC/OAVM to adopt FY2026 financials and consider special resolutions.
Company reports reduced net loss of ₹28.06 lakhs on revenue of